Delays in the manufacture of flu vaccine in the US could lead to a shortage
in this year’s supply, say US health officials. One of the virus strains in this
year’s vaccine hasn’t grown as fast as expected in the lab. Two of the four
companies making the US vaccine have hit this problem. The Centers for Disease
Control and Prevention in Atlanta and the Food and Drug Administration are
working with manufacturers to figure out when and how much vaccine will be
available. Officials are confident that enough will be produced to vaccinate
people at highest risk.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New Scientist articles
1
Rebooting stem cells builds aged muscles and assists injury recovery
2
Why autism pioneer Uta Frith wants to dismantle the spectrum
3
Neanderthals treated a dental cavity by drilling into the tooth
4
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
5
First test of CO2 removal with green sand finds no harm to marine life
6
Where did the laws of physics come from? I think I've found the answer
7
Asteroid set to fly very close to Earth
8
CAR T-cell therapy bolstered by stiffening up cancer cells first
9
Where do you think your ‘self’ is? Your answer is revealing
10
SpaceX is about to launch tallest and most powerful rocket in history
